Recursion Pharmaceuticals (RXRX) FCF Margin Growth (3y) (2023 - 2026)
Recursion Pharmaceuticals (RXRX) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Recursion Pharmaceuticals | 1.69 Bn | 1.14 Bn | -3.82 Mn | -73,348.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73,348.00 |
| Mar 31, 2026 | -61,022.00 |
| Dec 31, 2025 | 19,396.00 |
| Sep 30, 2025 | -195,748.00 |
| Jun 30, 2025 | 41,145.00 |
| Mar 31, 2025 | -227,705.00 |
| Dec 31, 2024 | 2,298.00 |
| Sep 30, 2024 | 141,472.00 |
| Jun 30, 2024 | 177,005.00 |
| Mar 31, 2024 | 43,809.00 |
| Dec 31, 2023 | -97,150.00 |
| Sep 30, 2023 | 128,649.00 |
| Jun 30, 2023 | 912,109.00 |
| Mar 31, 2023 | 2.90 Mn |